Home
Matthew Gline, CEO: Roivant Sciences ROIV Planned sale · Filed 25/12/15
Trade details
- Type
- Planned sale notice
- Person
- Matthew GlineCEO
- Planned sale date
- 25/12/15
- Filed
- 25/12/15
0.3% of shares outstanding to be sold
Roivant Sciences trades, last 26 weeks
What else happened in Roivant Sciences around then
Filed or reported within 30 days of the trade day · 25/11/15~01/14Matthew Gline's recent trades
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/20
Traded 04/16
- Matthew Gline
Planned saleRoivant Sciences
Planned saleRoivant Sciences
ROIV
$8.4M
289,774 sh
$8.4M
Filed 04/16
Traded 04/16
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$20.5M
943,527 sh
$20.5M
Filed 25/12/17
Traded 25/12/15
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$12.3M
566,116 sh
$12.3M
Filed 25/12/17
Traded 25/12/15
- Matthew Gline
SellRoivant Sciences
SellRoivant Sciences
ROIV
$5M
230,357 sh
$5M
Filed 25/12/17
Traded 25/12/15